Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase IV study of safety and efficacy of docetaxel in combination with prednisone in advanced hormone refractory prostate cancer treatment

X
Trial Profile

Phase IV study of safety and efficacy of docetaxel in combination with prednisone in advanced hormone refractory prostate cancer treatment

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 07 Apr 2022

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Docetaxel (Primary) ; Prednisone
  • Indications Prostate cancer
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Aventis Pharma; Sanofi
  • Most Recent Events

    • 27 May 2011 New source identified and integrated (European Clinical Trials Database; EudraCT2005-001873-91).
    • 21 Apr 2008 The expected completion date for this trial is now 1 Oct 2007.
    • 15 Apr 2008 Status changed from in progress to completed, reported by ClinicalTrials.gov.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top